1,3 AND 1,3,5 SUBSTITUTED IMIDAZOLES AS ANTIHYPERTENSIVA
申请人:Eldrug S.A.
公开号:EP2188279A2
公开(公告)日:2010-05-26
[EN] COMPOUNDS<br/>[FR] COMPOSÉS
申请人:ELDRUG S A
公开号:WO2009016514A2
公开(公告)日:2009-02-05
The present invention provides novel 1,5 and 1,3, 5 -substituted imidazole compounds of formulas (I), (IIa), (IIIb) in hydrophilic or lipophilic form, which are useful as angiotensin II AT1 receptor antagonists with sympathetic suppressant properties. In particular, the invention provides pharmaceutical compositions containing the pharmacophoric groups of Losartan and Clonidine as well compounds, processes and intermediates for preparing compounds and their use in methods of treating hypertension and cardiovascular diseases through Renin Angiotensin System (RAS) and Sympathetic System (SS). Alkylated histamine based double action Saltans are lipophilic and can act transdermally.